Abiopharma

🔍 Brennan Katherine (Executive)

Company: MARSH & MCLENNAN COMPANIES, INC. (MRSH)

Report Date: 2026-09-02

Detailed Transactions and Holdings:

• Acquired 1,197 shares of Common Stock at $83.046 per share (Direct)
  Date: 2026-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,527.00 | transaction_form_type: 4
• Sold 1,197 shares of Common Stock at $187.899 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,330.00 | transaction_form_type: 4
• Sold 1,197 shares of Stock Options (Right to Buy) at $83.046 per share (Derivative)
  Date: 2026-09-02 | Code: M | Expires: 2028-02-20 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These options were granted on February 21, 2018 and vested in four equal annual installments on February 21st of 2019, 2020, 2021 and 2022.